Physician profile
Charles Marvin Gordon
NPI 1275825135
$208,377.89
in general payments reported to CMS, 2019-2025
45 companies · $7,122 in 2025
The $7,122 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $35K · 2021: $56K · 2022: $67K · 2023: $17K · 2024: $7,877 · 2025: $7,122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Food and Beverage: $7,342 · Royalty Or License: $6,139 · Travel and Lodging: $3,692.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,900.00 |
| Food and Beverage | $7,342.44 |
| Royalty Or License | $6,138.56 |
| Travel and Lodging | $3,692.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| 4web, INC. | $99,412.92 | 2019-2025 | Spine Truss System |
| Royal Biologics, INC. | $20,753.76 | 2020-2025 | Fibrinet, Bio-Reign 3d, Maxx Bmc |
| Ulrich Medical USA, INC. | $18,374.47 | 2021-2022 | |
| Seaspine Orthopedics Corporation | $11,049.29 | 2020-2022 | |
| Stryker Corporation | $10,968.02 | 2019-2021 | |
| Integrity Implants INC. | $10,958.37 | 2020-2022 | |
| Orthofix Medical, INC. | $6,666.25 | 2023-2025 | Waveform C, Mariner Mis, Firebird |
| Medtronic USA, INC. | $6,321.21 | 2019-2020 | |
| Medtronic, INC. | $3,746.57 | 2021 | |
| Alphatec Spine, INC | $3,337.34 | 2020-2021 | |
| Medical Device Business Services, INC. | $3,201.52 | 2019 | |
| Si-Bone, INC. | $2,616.15 | 2019-2025 | |
| Life Spine, INC. | $2,459.27 | 2024-2025 | Gruve Anterior Cervical Plate System, Prolink Barb, Dyna-Link Ti |
| Spinal Elements, INC. | $1,511.53 | 2020-2025 | |
| Djo, LLC | $922.09 | 2019-2025 | Cmf |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cerapedics INC. | $854.47 | 2022-2024 | I-Factor Peptide Enhanced Bone Graft |
| Mirus, LLC | $814.07 | 2022 | |
| Zimmer Biomet Holdings, INC. | $742.20 | 2019-2021 | |
| Depuy Synthes Sales INC. | $710.31 | 2019-2023 | Orthovisc, Monovisc |
| Biocomposites INC | $321.54 | 2021-2025 | Stimulan |
| Providence Medical Technology, INC. | $258.76 | 2021-2023 | |
| Globus Medical, INC. | $225.05 | 2019 | |
| Precision Spine, INC. | $204.70 | 2020-2025 | |
| Titan Spine, LLC | $194.78 | 2019 | |
| Spineology INC. | $192.89 | 2023 | Optimesh Expandable Interbody Fusion System |
| Novapproach Spine, LLC | $185.05 | 2025 | Onelif |
| Abbott Laboratories | $179.45 | 2021-2025 | Eterna |
| Baxter Healthcare | $175.41 | 2019-2024 | Floseal |
| Bioventus LLC | $147.80 | 2025 | |
| Sanara Medtech INC. | $123.97 | 2021 | |
| Boston Scientific Corporation | $120.05 | 2021 | |
| Terumo Bct, INC. | $108.00 | 2021 | |
| Orthalign INC | $74.66 | 2025 | Orthalign Plus |
| Pacira Therapeutics, INC. | $72.92 | 2019-2020 | |
| Carlsmed, INC. | $70.04 | 2024-2025 | Aprevo |
| Corelink, LLC | $70.02 | 2023 | |
| Davol INC. | $53.21 | 2024 | Arista Ah Flexitip |
| Ferring Pharmaceuticals INC. | $48.29 | 2019-2024 | Euflexxa |
| Sanofi-Aventis U.S. LLC | $32.35 | 2019 | |
| Ethicon US, LLC | $31.74 | 2020-2024 | Surgiflo Hemostatic Matrix |
| Nevro Corp. | $23.17 | 2019 | |
| Spinal Simplicity, LLC | $15.46 | 2025 | Ha Minuteman G3-R |
| Horizon Therapeutics Plc | $14.00 | 2023 | Krystexxa |
| Brainlab, INC. | $8.75 | 2021 | |
| Electronic Waveform Lab, INC. | $6.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.